Article
Molecular genotyping of medullary thyroid carcinoma can predict tumor recurrence.
The American journal of surgical pathology - 1 Jan 2004
Sheikh Hina A, Tometsko Michael, Niehouse Laura, Aldeeb Dalal, Swalsky Patricia, Finkelstein Sydney, Barnes E Leon, Hunt Jennifer L
Abstract excerpt
Medullary thyroid carcinoma can have an aggressive behavior, and little is known about the molecular basis for clinical outcome. Defining risk of recurrent or metastatic disease is difficult, and it has been limited to clinical and pathologic features, such as advanced age, cervical lymph node metastases, and stage at presentation. Using microdissection and genotyping, we studied 11 cases of medullary carcinoma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
